Literature DB >> 15880568

An intronic silencer element is responsible for specific zonal expression of glutamine synthetase in the rat liver.

Frank Gaunitz1, Danilo Deichsel, Kerstin Heise, Max Werth, Ulf Anderegg, Rolf Gebhardt.   

Abstract

The most striking phenomenon of glutamine synthetase (GS) expression in the liver is its unique restriction to cells surrounding the terminal hepatic venules. Expression is positively regulated by elements located in the 5'-upstream region and in the first intron of the gene. It was long believed that transcription factors present in GS-positive cells and absent in GS-negative cells are responsible for the phenomenon of zonal expression. However, strong enhancers are equally active in both types of cells. Therefore, the existence of a silencer mechanism in GS-negative hepatocytes was postulated. In the present study, a GS silencer element was investigated that was previously identified within the first intron and was shown to be able to prevent glucocorticoid-induced expression in cells negative for a transacting factor designated GS silencer element-binding protein. Reporter gene assays with the silencer element in combination with the most potent 5'-enhancer of the GS gene demonstrate that the silencer element is able to prevent enhancement mediated by the 5'-enhancer in combination with a heterologous as well as with the homologous promoter. More importantly, the effect of the silencer is shown to be restricted to GS-negative hepatocytes. In conclusion, the phenomenon of zonal expression of GS in the liver is caused by a protein present in GS-negative cells and absent in GS-positive cells that interacts with the silencer element in the first intron and not by a differential expression of enhancer-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880568     DOI: 10.1002/hep.20710

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Inborn error of amino acid synthesis: human glutamine synthetase deficiency.

Authors:  Johannes Häberle; Boris Görg; Annick Toutain; Frank Rutsch; Jean-François Benoist; Antoinette Gelot; Annie-Laure Suc; Hans Georg Koch; Freimut Schliess; Dieter Häussinger
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

2.  The Third Intron of the Interferon Regulatory Factor-8 Is an Initiator of Repressed Chromatin Restricting Its Expression in Non-Immune Cells.

Authors:  Mamduh Khateb; Nitsan Fourier; Ofer Barnea-Yizhar; Sigal Ram; Ekaterina Kovalev; Aviva Azriel; Ulfert Rand; Manabu Nakayama; Hansjörg Hauser; Lior Gepstein; Ben-Zion Levi
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

3.  The function of introns.

Authors:  Michal Chorev; Liran Carmel
Journal:  Front Genet       Date:  2012-04-13       Impact factor: 4.599

4.  Signal integration by the CYP1A1 promoter--a quantitative study.

Authors:  Pascal Schulthess; Alexandra Löffler; Silvia Vetter; Luisa Kreft; Michael Schwarz; Albert Braeuning; Nils Blüthgen
Journal:  Nucleic Acids Res       Date:  2015-05-01       Impact factor: 16.971

5.  A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity.

Authors:  Benjamin Hing; Scott Davidson; Marrisa Lear; Gerome Breen; John Quinn; Peter McGuffin; Alasdair MacKenzie
Journal:  Biol Psychiatry       Date:  2012-01-20       Impact factor: 13.382

Review 6.  Minireview on Glutamine Synthetase Deficiency, an Ultra-Rare Inborn Error of Amino Acid Biosynthesis.

Authors:  Marta Spodenkiewicz; Carmen Diez-Fernandez; Véronique Rüfenacht; Corinne Gemperle-Britschgi; Johannes Häberle
Journal:  Biology (Basel)       Date:  2016-10-19

7.  Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.

Authors:  Madeleine Austinat; Ruediger Dunsch; Christian Wittekind; Andrea Tannapfel; Rolf Gebhardt; Frank Gaunitz
Journal:  Mol Cancer       Date:  2008-02-18       Impact factor: 27.401

8.  Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.

Authors:  Qunfeng Wu; Marda Jorgensen; Joanna Song; Junmei Zhou; Chen Liu; Liya Pi
Journal:  Gastroenterol Res Pract       Date:  2016-10-18       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.